Lantern Pharma Inc (LTRN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.47M
Last updated: Nov 17, 2026 at 11:01 AM ET
Performance (10Y)
Upcoming Estimates
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 59.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 24.9, below 30, the oversold line.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about LTRN
News
LTRN Valuation
- P/B
- -1.5x
LTRN Profitability: Margins, ROIC and FCF
Lantern Pharma (LTRN) has an operating margin of 0.0% and a net margin of 0.0%.
- Operating margin
- 0.0%
- Net margin
- 0.0%
- ROE
- -400.9%
Lantern Pharma Competitors
The companies most similar to Lantern Pharma (LTRN) include Liminatus Pharma, Inc. Class A Common Stock, CNS Pharmaceuticals and Processa Pharmaceuticals.
Sector: Healthcare
Companies most similar to Lantern PharmaLTRN Bull Case vs Bear Case
Bull case
- LTRN beat EPS estimates in 87.5% of its last 8 reported quarters.
LTRN Earnings: Beat Rate and Next Report
Lantern Pharma (LTRN) beat the EPS estimate in 7 of the last 8 quarters (87.5%). Its next report is expected on Nov 17, 2026.
- Beat rate
- 7 of 8 quarters (87.5%)
- Average surprise
- 15.0%
- EPS estimate (fiscal period ending Dec 31, 2026)
- -$0.42
LTRN Earnings Date
LTRN reports Nov 17, 2026. The date is estimated.
LTRN Earnings Call
The latest LTRN earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptLTRN ETF Holders
GNG tracks 3 ETFs that hold LTRN. The largest weights:
- Dimensional U.S. Core Equity 2 ETF (DFAC), <0.01% of the fund
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Aug 14, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About LTRN
When does LTRN report earnings?
Lantern Pharma Inc (LTRN) is expected to report earnings on Nov 17, 2026.
Does LTRN pay dividends?
Lantern Pharma Inc (LTRN) does not currently pay a regular dividend.
What is LTRN's market cap?
Lantern Pharma Inc (LTRN) has a market capitalization of $6.47M with a current stock price of $0.39.
LTRN pages: Overview, Earnings, Forecast, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.